TEST DIRECTORY

0 selected

Laboratory：Akiruno

○PSA-ACT（Suspended beyond orders placed 03-31-2021）

CODE：02581 4

  • TEST NAME SPECIMEN
    REQUIREMENT
    （ｍL）     CONTAINER CAP COLOR STORE
    TEMPERATURE
    (STABILITY)     TURNAROUND
    TIME (DAY)     METHODOLOGY REFERENCE RANGE
    (UNIT)
  • INACTIVE
    PSA-ACT（Suspended beyond orders placed 03-31-2021）
    Serum
    0.5
    S09
    ↓
    A00     Refrigeration
     2-4 CLIA

    CLIA (Chemiluminescent immunoassay)
    A method in which after an antigen is reacted with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, in which the luminescence intensity of a chemiluminescent substrate is measured.

     3.4 or less (ng/mL)

COMMENT


The recommended cut-off value for distinguishing between benign prostate diseases and prostate cancer is 7.0 ng/mL.

CONTAINER

Notifications of URL changes/lab information added

ラボを選択してください

Choose a laboratory

Notifications of URL changes/lab information added

Laboratory List

Advanced search